Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial looked at erlotinib (Tarceva) for people with advanced non small cell lung cancer (NSCLC) who were not fit enough to have chemotherapy. This trial was supported by Cancer Research UK.
Recruitment start: 5 April 2005
Recruitment end: 1 April 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Siow-Ming Lee
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Roche
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/03/007.
Last reviewed: 8 January 2013
CRUK internal database number: 339
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
